ArticleChina CDC weekly2024
Characterization of a New HIV-1 Circulating Recombinant Form CRF142_BC - Yunnan, China, 2015 and 2021.
Article in China CDC weekly, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: Recombinant strains dominate the human immunodeficiency virus 1 (HIV-1) epidemic in China. Yunnan Province was the first region in China to report HIV-1 infections in batches. The long-term HIV-1 epidemic led to the generation of various recombinant forms. Among the 47 circulating recombinant forms (CRFs) reported in China, more than 20 were first identified in Yunnan Province. What is added by this report?: This study reported a previously unrecognized HIV-1 CRF (CRF142_BC) characterized by the insertion of four short subtype B fragments into the subtype C backbone. CRF142_BC was estimated to have emerged in the mid-1990s, close to the time of the emergence of most known CRF_BCs in China. What are the implications for public health practice?: The discovery of new CRFs will provide a basis for HIV-1 molecular tracing and intervention research. In addition, HIV-1 recombination can alter viral biological properties. The study of HIV-1 gene variants needs to be intensified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.